DMK Pharmaceuticals Regains Full Rights to Commercialize ZIMHI
21. Dezember 2023 08:15 ET
|
DMK Pharmaceuticals Corporation
SAN DIEGO, Dec. 21, 2023 (GLOBE NEWSWIRE) -- DMK Pharmaceuticals Corporation (Nasdaq: DMK) (“DMK”), a commercial stage neuro-biotech company primarily focused on developing and commercializing...